ArticleActa pharmacologica Sinica2015

The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells.

Ewa Augustin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.